Viewing Study NCT00192426



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192426
Status: COMPLETED
Last Update Posted: 2006-10-03
First Post: 2005-09-13

Brief Title: Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children
Sponsor: MedImmune LLC
Organization: MedImmune LLC

Study Overview

Official Title: A Prospective Randomized Partially-Blinded Placebo-Controlled Phase III Multicenter Trial to Assess Safety Tolerability and Immunogenicity of Liquid CAIV-T Administered Concomitantly With OPV in Healthy Children
Status: COMPLETED
Status Verified Date: 2006-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phase III trial to evaluate the immune response to oral poliovirus vaccine OPV when administered concomitantly with CAIV-T to healthy children
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None